Evidence map›Paper›PMID 25654315›Full record

ReviewACS chemical neuroscience2015

Serotonergic Systems in the Pathophysiology of Ethanol Dependence: Relevance to Clinical Alcoholism.

Catherine A Marcinkiewcz

Open access · greenAbstract readReview
In one paragraph

Review in ACS chemical neuroscience, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 19 papers.

0numbers the graph read from it
0cells of the map it votes in
19citing papers in PubMed
1.7field-weighted citation impact, top 17% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

19 citing papers in PubMed, 42 citations in OpenAlex.

  1. Review
  2. Article
  3. Review
  4. Article
  5. The Effect of Serotonin 5-HTAddiction biology · 2025
    Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Serotonin 5-HTFrontiers in neuroscience · 2025
    Article
  11. Review
  12. Article
  13. Article
  14. Article
  15. Cells · 2022
    Article
  16. Article
  17. Article
  18. The serotonin 5-HTJournal of psychopharmacology (Oxford, England) · 2017
    Review
  19. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

1 author at 1 institution in 1 country.

Catherine A MarcinkiewczBowles Center for Alcohol Studies, University of North Carolina at Chapel Hill, Chapel Hill, North Carolina 27599, United States.
University of North Carolina at Chapel Hill · US

Funding

5HT2c-CRF interactions in the BNST: Relevance to anxiety and alcoholF32AA021319 · NIAAA · UNIV OF NORTH CAROLINA CHAPEL HILL · PI MARCINKIEWCZ, CATHERINE ANNE · 2013 to 2014
$107k
NIAAA NIH HHS 1F32AA021319-01A1NIAAA NIH HHS F32 AA021319
6 · The paper itself

Abstract

Alcoholism is a progressive brain disorder that is marked by increased sensitivity to the positive and negative reinforcing properties of ethanol, compulsive and habitual use despite negative consequences, and chronic relapse to alcohol drinking despite repeated attempts to reduce intake or abstain from alcohol. Emerging evidence from preclinical and clinical studies implicates serotonin (5-hydroxytryptamine; 5-HT) systems in the pathophysiology of alcohol dependence, suggesting that drugs targeting 5-HT systems may have utility in the treatment of alcohol use disorders. In this Review, we discuss the role of 5-HT systems in alcohol dependence with a focus on 5-HT interactions with neural circuits that govern all three stages of the addiction cycle. We attempt to clarify how 5-HT influences circuit function at these different stages with the goal of identifying neural targets for pharmacological treatment of this debilitating disorder.

Indexed as

Alcohol-Related DisordersAnimalsBrainCravingHumansReceptors, SerotoninReinforcement, PsychologySerotoninReceptors, SerotoninSerotonin5-HT2C receptorsalcoholanxietySerotoninSSRIswithdrawal

Identifiers

PMID25654315
PMCPMC10265695
OpenAlexW2312556712

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.